2VIN | Hydrolase | date | Dec 05, 2007 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Fragment-Based Discovery Of Mexiletine Derivatives As Orally Bioavailable Inhibitors Of Urokinase-Type Plasminogen Activ | ||||||||||||||
authors | M.Frederickson, O.Callaghan, G.Chessari, M.Congreve, S.R.Cowan, J.E.Matthews, R.Mcmenamin, D.Smith, M.Vinkovic, N.G.Wallis | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Urokinase-Type Plasminogen Activator Chain B Chain: A Fragment: Catalytic Domain, Residues 179-431 Synonym: Urokinase-Type Plasminogen Activator, Upa, U-Plasm Activator; Ec: 3.4.21.73 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | 505, ACT, SO4 BindingDB | enzyme | Hydrolase E.C.3.4.21.73 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator., Frederickson M, Callaghan O, Chessari G, Congreve M, Cowan SR, Matthews JE, McMenamin R, Smith DM, Vinkovic M, Wallis NG, J Med Chem. 2008 Jan 24;51(2):183-6. Epub 2007 Dec 29. PMID:18163548 |
Data retrieval |
View 2VIN in 3D |
Visual 3D analysis of 2VIN |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2VIN |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |